Skip to content
DraconiticResearch
Search Sources API
190,335 studies31 sourcesUpdated 59 min ago
Peer-reviewedCC BY-NC 4.0Nucleic Acids Research

NEAT1 remodeling rewires the MYC degradation pathway

  • Hagoon Jang1
  • Bo Kyoung Suh1
  • Feijie Zhang1
  • Angela Lin1
  • Mingdian Tan2
  • Yi Liu2
  • Mei-Sze Chua2
  • Samuel So2
  • Mark A Kay1
  1. 1Departments of Pediatrics and Genetics, Stanford University , Stanford, CA 94305 ,
  2. 2Department of Surgery, School of Medicine, Stanford University , Stanford, CA 94304 ,
Open at sourcePDFDOICite

Abstract

MYC is among the most frequently amplified oncogenes in human cancer, yet its intrinsically disordered nature has rendered it refractory to direct pharmacological targeting. Here, we demonstrate that the long noncoding RNA NEAT1_1 functions as a molecular gatekeeper that controls MYC protein stability by regulating its access to the E3 ubiquitin ligase UBR5. We show that NEAT1_1 forms a ribonucleoprotein (RNP) complex with both MYC and UBR5, and that NEAT1_1 suppression disrupts this interaction, leading to decreased MYC polyubiquitination and enhanced protein stability. To systematically map the regulatory architecture of NEAT1_1 without altering its abundance, we screened 88 antisense oligonucleotide (ASO) mixmers tiling across the transcript. Strikingly, this phenotypic screen identified region-specific mixmers that elicit bidirectional control over MYC, either driving robust MYC destabilization or promoting its stabilization in a strictly expression-independent manner. Mechanistically, MYC-destabilizing mixmers selectively enhance the interaction between MYC and UBR5 to accelerate proteasomal degradation. A focused CRISPR screen targeting the ubiquitin–proteasome pathway independently validated UBR5 as the essential E3 ligase mediating this mixmer-induced turnover. In vivo, our lead mixmer ASO_#24 significantly suppressed tumor growth in MYC-high xenografts, whereas MYC-low tumors remained unaffected. Our findings reveal that the functional output of a scaffold lncRNA is encoded in its sub-domain architecture rather than bulk transcript levels, establishing domain-specific RNA targeting as a tractable strategy to rewire protein turnover pathways for otherwise undruggable oncogenes.

Related

  1. Inhibition of FAK-Actin Pathway by Indoxyl Sulfate Suppresses Microvascular Remodeling in a Mouse Model of Chronic Kidney Disease
    Sean Michael Carr, Tharmarajan Ramprasath, Ming-Hui Zou
    CellsPeer-reviewedCC BY 4.0Surgery & anaesthesiaCrossref
  2. The GET pathway modulates azole susceptibility through sterol metabolic remodeling and protein trafficking in filamentous fungi
    Shuting Ye, Ziyu Cui, Mi Zhou +5
    mBioPeer-reviewedCC BY 4.0Full textInfectious diseaseCrossref
  3. Ferroptosis in Intervertebral Disc Degeneration: How the Extreme Microenvironment Rewires a Cell Death Network
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Tumour rewires host tryptophan metabolism to promote organism-wide immune suppression
    L. Garcia-Lopez, E. Saez-Carrion, M. L. Uribe +4
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. Ataxin-2 downregulation rewires neuronal and astrocytic metabolism to protect against TDP-43 toxicity
    Denise Gastaldo, Stephen Vito, Holly H. Black +6
    Cell ReportsPeer-reviewedCC BY-NC-ND 4.01 citedNeurologyCrossref

Cite

BibTeXRIS
BibTeX
@article{jang2026neat1,
  title = {{NEAT1 remodeling rewires the MYC degradation pathway}},
  author = {Hagoon Jang and Bo Kyoung Suh and Feijie Zhang and Angela Lin and Mingdian Tan and Yi Liu and Mei-Sze Chua and Samuel So and Mark A Kay},
  journal = {Nucleic Acids Research},
  year = {2026},
  month = oct,
  doi = {10.1093/nar/gkag1015},
  url = {https://academic.oup.com/nar/article/doi/10.1093/nar/gkag1015/8986596},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - NEAT1 remodeling rewires the MYC degradation pathway
AU  - Hagoon Jang
AU  - Bo Kyoung Suh
AU  - Feijie Zhang
AU  - Angela Lin
AU  - Mingdian Tan
AU  - Yi Liu
AU  - Mei-Sze Chua
AU  - Samuel So
AU  - Mark A Kay
PY  - 2026
DA  - 2026/10/23
JO  - Nucleic Acids Research
DO  - 10.1093/nar/gkag1015
UR  - https://academic.oup.com/nar/article/doi/10.1093/nar/gkag1015/8986596
AB  - MYC is among the most frequently amplified oncogenes in human cancer, yet its intrinsically disordered nature has rendered it refractory to direct pharmacological targeting. Here, we demonstrate that the long noncoding RNA NEAT1_1 functions as a molecular gatekeeper that controls MYC protein stability by regulating its access to the E3 ubiquitin ligase UBR5. We show that NEAT1_1 forms a ribonucleoprotein (RNP) complex with both MYC and UBR5, and that NEAT1_1 suppression disrupts this interaction, leading to decreased MYC polyubiquitination and enhanced protein stability. To systematically map the regulatory architecture of NEAT1_1 without altering its abundance, we screened 88 antisense oligonucleotide (ASO) mixmers tiling across the transcript. Strikingly, this phenotypic screen identified region-specific mixmers that elicit bidirectional control over MYC, either driving robust MYC destabilization or promoting its stabilization in a strictly expression-independent manner. Mechanistically, MYC-destabilizing mixmers selectively enhance the interaction between MYC and UBR5 to accelerate proteasomal degradation. A focused CRISPR screen targeting the ubiquitin–proteasome pathway independently validated UBR5 as the essential E3 ligase mediating this mixmer-induced turnover. In vivo, our lead mixmer ASO_#24 significantly suppressed tumor growth in MYC-high xenografts, whereas MYC-low tumors remained unaffected. Our findings reveal that the functional output of a scaffold lncRNA is encoded in its sub-domain architecture rather than bulk transcript levels, establishing domain-specific RNA targeting as a tractable strategy to rewire protein turnover pathways for otherwise undruggable oncogenes.
SN  - 0305-1048
SN  - 1362-4962
ER  -